Cargando…

Factors influencing warfarin response in hospitalized patients

The objective of this study was to investigate the influence of simultaneous factors that potentially keep patients far from achieving target INR range at discharge in hospitalized patients. Prospective cross-sectional observational study conducted at the Cardiology Department and Intensive Care Uni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Aziz, Mahmoud I., Ali, Mostafa A. Sayed, Hassan, Ayman K.M., Elfaham, Tahani H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669420/ https://www.ncbi.nlm.nih.gov/pubmed/26702259 http://dx.doi.org/10.1016/j.jsps.2015.02.004

Ejemplares similares

Ocular administration of acetazolamide microsponges in situ gel formulations
por: Obiedallah, Manar M., et al.
Publicado: (2018)

Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy
por: Sagar, Amitabh, et al.
Publicado: (2010)

Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
por: Lomonaco, Tommaso, et al.
Publicado: (2014)

Formulation and evaluation of simvastatin cubosomal nanoparticles for assessing its wound healing effect
por: Ahmed, Lamiaa M., et al.
Publicado: (2023)

Identification of environmental and genetic factors that influence warfarin time in therapeutic range
por: Botton, Mariana R., et al.
Publicado: (2020)

Influence of andrographolide on the pharmacokinetics of warfarin in rats
por: Zhang, Xiaoli, et al.
Publicado: (2018)

Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
por: Khansari, Nakisa, et al.
Publicado: (2022)

A factor VII-based method for the prediction of anticoagulant response to warfarin
por: Ooi, Qing-Xi, et al.
Publicado: (2018)

Warfarin overactivity
por: Yamanel, L, et al.
Publicado: (2005)

Factors predicting the spontaneous passage of a ureteric calculus of ⩽10 mm
por: Ahmed, Abul-fotouh, et al.
Publicado: (2015)

Warfarin Quality Metrics for Hospitalized Older Adults
por: Cohen, Jessica, et al.
Publicado: (2018)

The Influence of Ethnicity on Warfarin Dosage Requirements in the Chilean Population
por: Subiabre, Valeska, et al.
Publicado: (2015)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
por: AL-Eitan, Laith N, et al.
Publicado: (2019)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021)

Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana
por: Mwita, Julius C., et al.
Publicado: (2017)

Bidirectional Influences of Cranberry on the Pharmacokinetics and Pharmacodynamics of Warfarin with Mechanism Elucidation
por: Yu, Chung-Ping, et al.
Publicado: (2021)

Warfarin-Induced Skin Necrosis Despite Enoxaparin Bridging Therapy
por: Wali, Mohamed, et al.
Publicado: (2022)

Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement
por: Wang, Xiaowu, et al.
Publicado: (2018)

Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China
por: Zhao, Shujuan, et al.
Publicado: (2017)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Warfarin-related Nephropathy
por: Golla, Anvesh, et al.
Publicado: (2018)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Effects of propolis on warfarin efficacy
por: Akbay, Esin, et al.
Publicado: (2017)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Formulation and characterization of chlorhexidine HCl nanoemulsion as a promising antibacterial root canal irrigant: in-vitro and ex-vivo studies
por: Abdelmonem, Rehab, et al.
Publicado: (2019)

Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study
por: Schulman, Sam, et al.
Publicado: (2008)

Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients
por: Tanaka, Tomotaka, et al.
Publicado: (2021)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2016)

Effect of patient-specific factors on weekly warfarin dose
por: Whitley, Heather P, et al.
Publicado: (2007)

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
por: Uygungül, Evren, et al.
Publicado: (2014)

Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)

The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
por: Francis, J. L., et al.
Publicado: (1992)

Novel oral anticoagulants and the 73rd anniversary of historical warfarin
por: Shehab, Abdulla, et al.
Publicado: (2016)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

Prevalence and factors associated with psychological distress among patients on warfarin at the Uganda Heart Institute, Mulago Hospital
por: Naisanga, Molly, et al.
Publicado: (2022)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q00qpuq9cg0eid6r6hr7qvv3tk